Results 101 to 110 of about 1,195 (187)

Deguelin induces cellular ceramide synthesis.

, 2013
Hep-2 cells were exposed to 100 µM of deguelin with or without fumonisin B1 (20 µM) for indicated time points, intracellular ceramide level was analyzed using methods mentioned above (A). Hep-2 cells were treated with fumonisin B1 (20 µM) or C6-ceramide (
Chun-cheng Lu (276392), Chao Ji (276390), Zhi-gang Bi (276391), Bing Gu (276393), Lei Cheng (171055), Rong Wang (59795), Yan-li Yang (276389)   +6 more
core   +1 more source

Supplementary Table 1 from A Novel Derivative of the Natural Agent Deguelin for Cancer Chemoprevention and Therapy

, 2008
Supplementary Table 1 from A Novel Derivative of the Natural Agent Deguelin for Cancer Chemoprevention and ...
Gordon Mills (499661), Young-Ger Suh (1456891), Ho-Young Lee (1612351), Jakyung Yoo (406971), Yoo-Shin Kim (1902748), Waun Ki Hong (14879295), Dong Jo Chang (2025631), Woo-Young Kim (86243), Kyu-Won Kim (43973), Bryan Hennessy (590686), Seung-Ho Han (536628), Seung-Yong Geo (15090807), Hae Jin Kang (15090804), Hyun-Ju Park (2025628)   +13 more
core   +1 more source

Total Synthesis of dl-Deguelin

Agricultural and Biological Chemistry, 1960
FUKAMI, Hiroshi, ODA, Junichi, SAKATA, Genzo, NAKAJIMA, Minoru   +3 more
openaire   +3 more sources

Concise Synthesis of the Chemopreventitive Agent (±)-Deguelin via a Key 6-Endo Hydroarylation

, 2016
A concise total synthesis of (±)-deguelin was achieved with a longest linear sequence of six steps in 68% yield.
Dalibor Sames (1432975), Stefan J. Pastine (2296567)   +1 more
core   +1 more source

Deguelin gavage is well tolerated.

, 2013
Bodyweight is determined before and after Deguelin treatment. The gain in bodyweight is a sign for good tolerance of the substance. The graph represents the increases in bodyweight vs. weight at begin of the experiment.
Bertram Scheller (318724), Johannes Holfeld (318725), Nora Karnowski (318722), Patrick Paulus (318716), Anja Urbschat (318726), Pia Ockelmann (318718), Sabine Tacke (318720), Peter Ellinghaus (318723), Kai Zacharowski (77285)   +8 more
core   +1 more source

Correction: A Novel Derivative of Deguelin [PDF]

Cancer Prevention Research, 2009
openaire   +1 more source

Deguelin regulates cell cycle and nuclear pore complex protein Nup98 and Nup88 in U937 cells in vitro

, 2007
OBJECTIVE: To investigate antitumor activity and molecular mechanism of deguelin to the human U937 leukaemia cells and to explore the mechanisms regulating cell cycle and nucleoporin 98 (Nup98) and nucleoporin 88 (Nup88) in vitro. METHODS: The effects of
Chen, WH, Wu, QL, Cui, GH, Liu, HL, Chen, Y, He, J   +5 more
core  

Deguelin`in deneysel meme kanseri tedavisindeki etkinliğinin araştırılması

, 2021
Breast cancer is the second most common type of cancer among women in the USA and it is one of the most studied cancer type in the world. As an alternative for the standard treatment used in breast cancer there is a need for agents which are more potent and have less toxicity.
openaire   +1 more source

Drug combination treatment as a strategy for inhibiting human adenovirus replication. [PDF]

Antiviral Res
Dodge MJ, MacNeil KM, Tessier TM, Evans AM, Palmateer KR, Weinberg JB, Mymryk JS.   +6 more
europepmc   +1 more source

Correction: Deguelin inhibits growth and prolactin synthesis in prolactinomas by targeting the PI3K/AKT/CREB3L1 pathway and ornithine decarboxylase. [PDF]

Acta Pharmacol Sin
Gong L, Liu CX, Cheng JH, Guo J, Li B, Wang HY, Liu M, Wang JL, Li XJ, Fang QY, Yi ZY, Li CZ, Zhang YZ, Xie WY.   +13 more
europepmc   +1 more source